FDA OKs First Personal Exoskeleton System To Help Paraplegics Walk
This article was originally published in The Gray Sheet
Executive Summary
ReWalk Robotics' ReWalk personal exoskeleton system gained FDA market go-ahead June 26. It’s a wearable, motorized device that allows paraplegics with some spinal cord injuries to walk.
You may also be interested in...
Argo Medical And Ekso Bionics Make Strides With Robotic Walking Devices
Two emerging companies – Argo Medical Technologies Inc. and Ekso Bionics Inc. – are making substantial headway with robotic devices designed to help paralyzed patients regain the ability to walk.
Argo Preps 510(k) Application For ReWalk Exoskeleton For Home Use
The firm launched the CE-marked, first-of-its-kind device for personal home use in Europe in early September at the International Spinal Cord Society meeting in London.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.